Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is rifampin a safe and effective treatment for pruritus caused by chronic cholestasis?

Nature Clinical Practice Gastroenterology & Hepatology volume 4, pages 200–201 (2007)Cite this article

boxed-textKhurana S and Singh P (2006) Rifampin is safe for treatment of pruritus due to chronic cholestasis: a meta-analysis of prospective randomized-controlled trials. Liver Int 26: 943–948

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. McElroy PD et al. (2005) National survey to measure rates of liver injury, hospitalization, and death associated with rifampin and pyrazinamide for latent tuberculosis infection. Clin Infect Dis 41: 1125–1133

    Article  Google Scholar 

  2. Gorski JC et al. (2003) The effects of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity. Clin Pharmacol Ther 74: 275–287

    Article  CAS  Google Scholar 

  3. Prince MI et al. (2002) Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis. Gut 50: 436–439

    Article  CAS  Google Scholar 

  4. Muthukumar T et al. (2002) Acute renal failure due to rifampin: a study of 25 patients. Am J Kidney Dis 40: 690–696

    Article  CAS  Google Scholar 

  5. Khokhar O et al. (2005) Autoimmune hepatitis and thyroiditis associated with rifampin and pyrazinamide prophylaxis: an unusual reaction. Dig Dis Sci 50: 207–221

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Toronto Western Hospital, 399 Bathurst Street, 6B Fell #154, Toronto, ON M5T 2S8, Canada jenny.heathcote@utoronto.ca

Authors and Affiliations

  1. EJ Heathcote is a Professor of Medicine at the University of Toronto, Toronto, Canada.,

    E Jenny Heathcote

Authors
  1. E Jenny Heathcote
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Heathcote, E. Is rifampin a safe and effective treatment for pruritus caused by chronic cholestasis?. Nat Rev Gastroenterol Hepatol 4, 200–201 (2007). https://doi.org/10.1038/ncpgasthep0746

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep0746

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing